These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 25143000)

  • 1. MicroRNA-155 deficiency enhances the recruitment and functions of myeloid-derived suppressor cells in tumor microenvironment and promotes solid tumor growth.
    Wang J; Yu F; Jia X; Iwanowycz S; Wang Y; Huang S; Ai W; Fan D
    Int J Cancer; 2015 Mar; 136(6):E602-13. PubMed ID: 25143000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-494 is required for the accumulation and functions of tumor-expanded myeloid-derived suppressor cells via targeting of PTEN.
    Liu Y; Lai L; Chen Q; Song Y; Xu S; Ma F; Wang X; Wang J; Yu H; Cao X; Wang Q
    J Immunol; 2012 Jun; 188(11):5500-10. PubMed ID: 22544933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloid-derived suppressor cells accumulate among myeloid cells contributing to tumor growth in matrix metalloproteinase 12 knockout mice.
    Li J; Zhang X; Liu Q; Yang M; Zhou Z; Ye Y; Zhou Z; He X; Wang L
    Cell Immunol; 2018 May; 327():1-12. PubMed ID: 29555056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual negative roles of C/EBPα in the expansion and pro-tumor functions of MDSCs.
    Mackert JR; Qu P; Min Y; Johnson PF; Yang L; Lin PC
    Sci Rep; 2017 Oct; 7(1):14048. PubMed ID: 29070836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of mTOR pathway in myeloid-derived suppressor cells stimulates cancer cell proliferation and metastasis in lal(-/-) mice.
    Zhao T; Du H; Ding X; Walls K; Yan C
    Oncogene; 2015 Apr; 34(15):1938-48. PubMed ID: 24882582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor conditions induce bone marrow expansion of granulocytic, but not monocytic, immunosuppressive leukocytes with increased CXCR2 expression in mice.
    Bian Z; Shi L; Venkataramani M; Abdelaal AM; Culpepper C; Kidder K; Liang H; Zen K; Liu Y
    Eur J Immunol; 2018 Mar; 48(3):532-542. PubMed ID: 29120053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation.
    Noman MZ; Desantis G; Janji B; Hasmim M; Karray S; Dessen P; Bronte V; Chouaib S
    J Exp Med; 2014 May; 211(5):781-90. PubMed ID: 24778419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-155-deficient bone marrow promotes tumor metastasis.
    Yu F; Jia X; Du F; Wang J; Wang Y; Ai W; Fan D
    Mol Cancer Res; 2013 Aug; 11(8):923-36. PubMed ID: 23666369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-9 promotes G-MDSC recruitment and tumor proliferation by targeting SOCS3 in breast cancer.
    Gu X; Wei F; Tong J; Liu Y; Chen S; Zheng L; Xing Y
    FASEB J; 2024 Jan; 38(1):e23388. PubMed ID: 38145323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-486 promotes proliferation and suppresses apoptosis in myeloid cells by targeting Cebpa in vitro.
    Jiang J; Gao Q; Gong Y; Huang L; Lin H; Zhou X; Liang X; Guo W
    Cancer Med; 2018 Sep; 7(9):4627-4638. PubMed ID: 30073773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical role of PPARγ in myeloid-derived suppressor cell-stimulated cancer cell proliferation and metastasis.
    Zhao T; Du H; Blum JS; Yan C
    Oncotarget; 2016 Jan; 7(2):1529-43. PubMed ID: 26625314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-9 Regulates the Differentiation and Function of Myeloid-Derived Suppressor Cells via Targeting Runx1.
    Tian J; Rui K; Tang X; Ma J; Wang Y; Tian X; Zhang Y; Xu H; Lu L; Wang S
    J Immunol; 2015 Aug; 195(3):1301-11. PubMed ID: 26091714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-21 regulates immunosuppression mediated by myeloid-derived suppressor cells by impairing RUNX1-YAP interaction in lung cancer.
    Meng G; Wei J; Wang Y; Qu D; Zhang J
    Cancer Cell Int; 2020; 20():495. PubMed ID: 33061847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-Promoting Effects of Myeloid-Derived Suppressor Cells Are Potentiated by Hypoxia-Induced Expression of miR-210.
    Noman MZ; Janji B; Hu S; Wu JC; Martelli F; Bronte V; Chouaib S
    Cancer Res; 2015 Sep; 75(18):3771-87. PubMed ID: 26206559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressive effects of hypoxia-induced glioma exosomes through myeloid-derived suppressor cells via the miR-10a/Rora and miR-21/Pten Pathways.
    Guo X; Qiu W; Liu Q; Qian M; Wang S; Zhang Z; Gao X; Chen Z; Xue H; Li G
    Oncogene; 2018 Aug; 37(31):4239-4259. PubMed ID: 29713056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-infiltrating monocytic myeloid-derived suppressor cells mediate CCR5-dependent recruitment of regulatory T cells favoring tumor growth.
    Schlecker E; Stojanovic A; Eisen C; Quack C; Falk CS; Umansky V; Cerwenka A
    J Immunol; 2012 Dec; 189(12):5602-11. PubMed ID: 23152559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of prolyl hydroxylase-2 in myeloid cells and T-lymphocytes impairs tumor development.
    Mamlouk S; Kalucka J; Singh RP; Franke K; Muschter A; Langer A; Jakob C; Gassmann M; Baretton GB; Wielockx B
    Int J Cancer; 2014 Feb; 134(4):849-58. PubMed ID: 23913502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rgs2 mediates pro-angiogenic function of myeloid derived suppressor cells in the tumor microenvironment via upregulation of MCP-1.
    Boelte KC; Gordy LE; Joyce S; Thompson MA; Yang L; Lin PC
    PLoS One; 2011 Apr; 6(4):e18534. PubMed ID: 21494556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HMGB1 enhances immune suppression by facilitating the differentiation and suppressive activity of myeloid-derived suppressor cells.
    Parker KH; Sinha P; Horn LA; Clements VK; Yang H; Li J; Tracey KJ; Ostrand-Rosenberg S
    Cancer Res; 2014 Oct; 74(20):5723-33. PubMed ID: 25164013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 6-Thioguanine-loaded polymeric micelles deplete myeloid-derived suppressor cells and enhance the efficacy of T cell immunotherapy in tumor-bearing mice.
    Jeanbart L; Kourtis IC; van der Vlies AJ; Swartz MA; Hubbell JA
    Cancer Immunol Immunother; 2015 Aug; 64(8):1033-46. PubMed ID: 25982370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.